{"name":"xCures","slug":"xcures","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":300000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Balversa","genericName":"Balversa","slug":"balversa","revenue":300000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":300000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Balversa","genericName":"Balversa","slug":"balversa","indication":"Metastatic urothelial carcinoma","status":"discontinued","revenue":300000000}]}],"pipeline":[{"name":"Balversa","genericName":"Balversa","slug":"balversa","phase":"discontinued","mechanism":"Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 3","indications":["Metastatic urothelial carcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcDBtTjR6dGE4LWNaRFZJaFh0MWxqV0FUNjZEWm5CYjZrUV9jN01EUzZYWVhGSUR5UUJldkFWTTZiTE8xdUNqd0habHh1TFlwWndhdlJDTTFZVG9FTmZqSXBFU1NBZjJfVWZaVXpvSDJ5QmhJOWhGV3VaaldZNktCZ2lGbGF4cG4zX3NRd0hUM0pRY183eWtlUmJvYmJpOGVJaFV5MjkwRm9yWWJ2Q1N6OVFVYnFEaXdRNVFJWg?oc=5","date":"2026-03-16","type":"pipeline","source":"CNBC","summary":"CNBC Cures: Acadia Pharmaceuticals CEO on scaling rare and neuro-focused drugs - CNBC","headline":"CNBC Cures: Acadia Pharmaceuticals CEO on scaling rare and neuro-focused drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNQm9qZFpBZ0NIWEhWRW5CM2czS2RSMTJZN0Q5aXc1UWJFbFE1MjJLY0IwanN4VUhIaWhOQjdKRTI5SFFZTGhaNTZMQUE4NjY1WXl6bFJJV1RHNGN1aUZudDIxU2dZbVNpWmNkaXY4SVBzam9RcTR0UDE3cUxLNlZ0amRrdUFDdzNKV0g3djVNcmY?oc=5","date":"2026-02-27","type":"deal","source":"Pharmaceutical Technology","summary":"Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m - Pharmaceutical Technology","headline":"Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-07","type":"deal","source":"Hindustan Times","summary":"Ideal Cures pharma owner buys two homes for ₹190.1 crore | Mumbai news - Hindustan Times","headline":"Ideal Cures pharma owner buys two homes for ₹190.1 crore | Mumbai news","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-06","type":"deal","source":"The Economic Times","summary":"Pharma co Ideal Cures’ promoters buy two luxury apartments in Mumbai’s Worli for Rs 190 cr - The Economic Times","headline":"Pharma co Ideal Cures’ promoters buy two luxury apartments in Mumbai’s Worli for Rs 190 cr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQUGwxSHdYT1N0Vmw4ZmNDRlNGc3JLQ3ZtenlRV1RHUktCRThZc3diZ1lIT0xYV2Frekdjc0xrUGJTa21NajBnbkdabEVyMFBQTGl1Z0JlMzNiNzYwcVFRYWpaV0duRzM3QTNUdHZrMm9ub2c0TWhvbDZkbFdDUTd0ajhrdUJTdXRvR3VnVWhJU0xtbmN4?oc=5","date":"2025-12-02","type":"pipeline","source":"Yonkers Times","summary":"Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times","headline":"Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxONjZrcHd5enYyLTVnYy02NTEyS2ZGeWY3ZFBxeEFSd0t0dFV1ZzBhVU4zanpOM3dBb1Fhd2djNngtREZBeTFURzJ1Z1hzR05Zc2tXZ3dKQUhseURGRmQ2SjViM0hCWGRMbHNtMVh0WkhKbXlXdkxkWS1OLWRlc2FvVnEwd2tCTDJCT2FCVVk5OEFpSXBMeGFsVDlWbWtMelRCVjV1WkZyUHZUSUFyUUNYaGxpaVU?oc=5","date":"2025-11-04","type":"pipeline","source":"BioSpace","summary":"Opinion: Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - BioSpace","headline":"Opinion: Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPYXVpMzRqNGg0U0hiQlUzOHV2My1UTGFoTzNKUktncWpjSXh1OWhQYVY0a1RueC1GR2VPNTY4eUk5c2lqeVk4TERqX2hHa2dMa2I4Zm8tVUNwMzU2cjFxakxLTnotR2dKbk9OYWdidXU2YW9sOWhDM2VqMWx0SlExazY5dFRucW05dDVkWXhnU0V5VzVFUHpmY2xWbGQtZlM3UWxzUEdXT21NN0NjWWVRcE02MzlhY194a216V0RLLUlSNUlaTDk3cU5CYzFNTEFPQnU5WXJFN1gtWlctNG80OTdrbXpLbk1iSUpaWkNlb1pNNTA?oc=5","date":"2025-10-20","type":"pipeline","source":"Arnold Ventures","summary":"ORPHAN Cures Act: $8.8 Billion for the… - Arnold Ventures","headline":"ORPHAN Cures Act: $8.8 Billion for the…","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNamtUbFl4NHMwd1ptcFZjSHc5cjVtcjkxT2NaUmdZWGQ2cVd3ZE40bThKTEVleEI4U0pTS1FjUldIcDh3LXJsZk1DVDhjQm1VbVZoTFRraVg1d3RPOTNEeWU3Wm16Y1pvNlFCQm10WlNxdUlndjFFV1MzMkpNVWxleVRicVJERXJIODJzU0FhVV9HWGU0eUZsUEpUQQ?oc=5","date":"2025-09-08","type":"pipeline","source":"The Pharma Letter","summary":"One-shot cures, lasting challenges: gene therapy in 2025 - The Pharma Letter","headline":"One-shot cures, lasting challenges: gene therapy in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOU25wa3drUldHQmlNRXFmc2FPczVUdS1COTBDa0kzN1RtcTVNR295QllnazBEcWxnRXloZ3NwTHBqQ29IbS1nTjJ1VDJpT0hxRThtNmhLWnd5Mk1pcnp0a1R6QTduSnUtQ1dDU2tPd2xiM0xtOFd4bGxXOFh3bEp0eTZBcC01S1B3cDZZOVg4YXl1X0dMY3NKMFZUUnl2emFrUjlz?oc=5","date":"2025-06-30","type":"pipeline","source":"Fierce Pharma","summary":"Orphan Cures Act re-added to Trump tax bill as Senate prepares to begin vote-a-rama - Fierce Pharma","headline":"Orphan Cures Act re-added to Trump tax bill as Senate prepares to begin vote-a-rama","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jYjZNcjZ5NTV1U3d4aDc2SThac1hidDhnWElQbkJZMldsNmsyM0FKUjhlUFhyRHlnbi1PenB0WHpNdU5EZEg2eFRiMXNSVXBpZ1Fn?oc=5","date":"2025-06-17","type":"pipeline","source":"FirstWord Pharma","summary":"Pharma's hoped-for tweak to US drug pricing controls excluded from Senate bill - FirstWord Pharma","headline":"Pharma's hoped-for tweak to US drug pricing controls excluded from Senate bill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbk5YcFQwYUd3bktVUzk0ZmYtLVlKR1RkTnZlQk5xWURtSFdCQ0lXVkh6TVhnQzk2NGtub0NlY2RBcTZabmRQenFuZE1UM1V5THIxTG1lTkMyQzZZTEt0R0hDM3plSS1zdTJQYVJNYXViMHFUMG1aTDZadFppWnBfMkRPU3FFbXpqNXljc1p6YmNxRmZ1c3N6TXBwN2dJQ2VCVlVWdzBLbXJFUzQxSkVISENkdVBodw?oc=5","date":"2025-06-17","type":"pipeline","source":"Fierce Pharma","summary":"In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act - Fierce Pharma","headline":"In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE8tc2FtcWlPbjJOSnQ5S243ZkxtM21mUlJoamF5eGhFY1RfY0R6N09PZWRfaUVkTUh3NC1kNlBYQzB2M1J2R3ZpLTJTTzVZcWdwX1haaVBjWGwycm5tWXBXNFBVLVFwNkFSc0NsVHNWMEk2WExPTE81a3Vn?oc=5","date":"2024-07-22","type":"pipeline","source":"WHYY","summary":"Are financial incentives holding back cures? - WHYY","headline":"Are financial incentives holding back cures?","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}